NH

Nabil Hanna

BI Biogen Idec: 23 patents #1 of 60Top 2%
IP Idec Pharmaceuticals: 14 patents #2 of 30Top 7%
SB Smithkline Beckman: 6 patents #16 of 166Top 10%
SL Smithkline Beecham Limited: 4 patents #325 of 1,624Top 25%
AM Amp: 1 patents #694 of 1,260Top 60%
📍 Harrisburg, PA: #8 of 635 inventorsTop 2%
🗺 Pennsylvania: #649 of 74,527 inventorsTop 1%
Overall (All Time): #53,049 of 4,157,543Top 2%
51
Patents All Time

Issued Patents All Time

Showing 26–50 of 51 patents

Patent #TitleCo-InventorsDate
6682734 Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma Darrell R. Anderson, John Leonard, Roland A. Newman, Mitchell E. Reff, William H. Rastetter 2004-01-27
6506383 Methods of suppressing immune responses to transplanted tissues and organs with gp39-specific antibodies Amelia Black, Eduardo A. Padlan, Roland A. Newman 2003-01-14
6440418 Methods of treating autoimmune diseases with gp39-specific antibodies Amelia Black, Eduardo A. Padlan, Roland A. Newman 2002-08-27
6399061 Chimeric and radiolabelled antibodies specific to human CD20 antigen and use thereof for treatment of B-cell lymphoma Darrell R. Anderson, Roland A. Newman, Mitchell E. Reff, William H. Rastetter 2002-06-04
6136310 Recombinant anti-CD4 antibodies for human therapy Roland A. Newman, Mitchell E. Reff 2000-10-24
6113898 Human B7.1-specific primatized antibodies and transfectomas expressing said antibodies Darrell R. Anderson, Peter Brams, William S. Shestowsky, Cheryl Heard 2000-09-05
6001358 Humanized antibodies to human gp39, compositions containing thereof Amelia Black, Eduardo A. Padlan, Roland A. Newman 1999-12-14
5843439 Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma Darrell R. Anderson, John Leonard, Roland A. Newman, Mitchell E. Reff, William H. Rastetter 1998-12-01
5776456 Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma Darrell R. Anderson, John Leonard, Roland A. Newman, Mitchell E. Reff, William H. Rastetter 1998-07-07
5756096 Recombinant antibodies for human therapy Roland A. Newman, Ronald W. Raab 1998-05-26
5750105 Recombinant antibodies for human therapy Roland A. Newman, Ronald W. Raab 1998-05-12
5736137 Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma Darrell R. Anderson, John Leonard, Roland A. Newman, Mitchell E. Reff, William H. Rastetter 1998-04-07
5693780 Recombinant antibodies for human therapy Roland A. Newman, Ronald W. Raab 1997-12-02
5681722 Recombinant antibodies for human therapy Roland A. Newman, Ronald W. Raab 1997-10-28
5658570 Recombinant antibodies for human therapy Roland A. Newman, Ronald W. Raab 1997-08-19
5317019 Inhibition of interleukin-1 and tumor necrosis factor production by monocytes and/or macrophages Paul E. Bender, Don Edgar Griswold, John Lee, Bartholomew Votta, Philip L. Simon +2 more 1994-05-31
5145858 Pyrrolo [1,2-a] imidazole and imidazo [1,2a] pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors Jerry L. Adams, Paul E. Bender, John G. Gleason, John F. Newton, Carl D. Perchonock 1992-09-08
5134150 Inhibition of the 5-lipoxygenase pathway Paul E. Bender, John G. Gleason, Don Edgar Griswold, Ivan Lantos, Kazys A. Razgaitis +2 more 1992-07-28
5002941 Pyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors Jerry L. Adams, Paul E. Bender, John G. Gleason, John F. Newton, Carl D. Perchonock +1 more 1991-03-26
4794114 Inhibition of interleukin-1 production by monocytes and/or macrophages Paul E. Bender, Don Edgar Griswold, John Lee 1988-12-27
4780470 Inhibition of interleukin-1 by monocytes and/or macrophages Paul E. Bender, Don Edgar Griswold, John Lee 1988-10-25
4778806 Inhibition of interleukin-1 production by monocytes and/or macrophages Paul E. Bender, Don Edgar Griswold, John Lee 1988-10-18
4751310 Inhibition of the 5-lipoxygenase pathway Paul E. Bender 1988-06-14
4719218 Pyrrolo[1,2-a]imidazole and pyrrolo[1,2-a]pyridine derivatives and their use as 5-lipoxygenase pathway inhibitor Paul E. Bender 1988-01-12
4686231 Inhibition of 5-lipoxygenase products Paul E. Bender, Don Edgar Griswold, Henry M. Sarau 1987-08-11